Boehringer Ingelheim Selects Ectris As Tradename For Depression Therapy
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Ectris has been chosen by Boehringer Ingelheim as the tradename for its depression treatment flibanserin. The name, which is awaiting FDA approval, is also awaiting clearance in Germany.